renal-cell-carcinoma

Documents about renal-cell-carcinoma

• Ketogenic Dietary Intervention to Improve Response to Immunotherapy in Patients With Metastatic Melanoma and Metastatic Kidney Cancer#481745ClinicalTrials.gov
• Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant Histology#195336ClinicalTrials.gov
• A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers#1008582ClinicalTrials.gov
• Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the Urothelium#851607ClinicalTrials.gov
• A Drug-Drug Interaction Study of the Effects of XL184 (Cabozantinib) on Rosiglitazone in Subjects With Solid Tumors#201718ClinicalTrials.gov
• PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors#843077ClinicalTrials.gov
• Should patients with low‐risk renal cell carcinoma be followed differently after nephron‐sparing surgery vs radical nephrectomy?#388037HAL (France)
• Inflammatory Markers (ICC, MCVL) and Nivolumab Response: Predicting Immunotherapy Success in Metastatic RCC#417549ClinicalTrials.gov
• VEG111485: A QTc Study of Pazopanib#812410ClinicalTrials.gov
• A Phase 1b Study Of Axitinib In Combination With Crizotinib In Patients With Advanced Solid Tumors#864092ClinicalTrials.gov
• Phase I Study With Sorafenib in Addition to Vinflunine in Metastatic Transitional Cell Carcinoma of the Urothelial Tract#844897ClinicalTrials.gov
• A Study Of Crizotinib Plus VEGF Inhibitor Combinations In Patients With Advanced Solid Tumors.#915907ClinicalTrials.gov
• Sunitinib Malate in Treating Patients With Locally Recurrent, Locally Advanced, Unresectable, or Metastatic Urinary Tract Cancer#825853ClinicalTrials.gov
• Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies#803666ClinicalTrials.gov
• Radiotherapy in Combination With Checkpoint Inhibition for Patients With Metastatic Kidney Cancer#906811ClinicalTrials.gov
• Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform (ELEPHAS-02)#394749ClinicalTrials.gov
• Evaluation of Predictive Markers for Toxicity and Efficacy in Patients With mccRCC Treated by Anti-VEGF Therapy#858807ClinicalTrials.gov
• GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours#981884ClinicalTrials.gov
• Treatment Resistance Following Anti-cancer Therapies#1046190ClinicalTrials.gov
• Whey Protein Supplement in Combination With Physical Exercise and Nutrition Program#863539ClinicalTrials.gov
• Phase II Trial Of PS-341 (Bortezomib) In Patients With Previously Treated Advanced Urothelial Tract Transitional Cell Carcinoma#888190ClinicalTrials.gov
• Study of ADCT-301 in Patients With Selected Advanced Solid Tumors#814039ClinicalTrials.gov
• A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies#901932ClinicalTrials.gov
• Development and validation of a machine learning-based radiomics model using 45-keV virtual monoenergetic images for differentiating fat-poor angiomyolipoma from clear cell renal cell carcinoma.#280950NCBI PubMed Central
• Prognostic Significance of Grade Discrepancy Between Primary Tumor and Venous Thrombus in Nonmetastatic Clear-cell Renal Cell Carcinoma: Analysis of the REMEMBER Registry and Implications for Adjuvant Therapy#378003HAL (France)
• Study of Nivolumab Plus Chemotherapy in Patients With Advanced Cancer (NivoPlus)#870778ClinicalTrials.gov
• Soft Drink and Juice Consumption and Renal Cell Carcinoma Incidence and Mortality in the European Prospective Investigation into Cancer and Nutrition#218006HAL (France)
• Supplementary Material for: Metastatic Renal Cell Carcinoma with Concomitant Minimal Change Disease: Enabling Immunotherapy with Rituximab – A Case Report.#322269Figshare
• Tumor heterogeneity on contrast-enhanced computed tomography outperforms attenuation ratio in differentiating renal cell carcinoma subtypes: a pathologic correlation study.#378460NCBI PubMed Central
• Circulating and Urinary Exosomal miRNA in Advanced Kidney Cancer (EXO-RENAL1)#992256ClinicalTrials.gov
• Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors#833985ClinicalTrials.gov
• A Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid Tumors#966510ClinicalTrials.gov
• Arsenic Trioxide in Treating Patients With Urothelial Cancer#804070ClinicalTrials.gov
• DNX-2440 for Resectable Colorectal Liver Metastasis#830024ClinicalTrials.gov
• A Phase 1 Study of Nivolumab (BMS-936558) in Subjects With Advanced or Recurrent Malignancies#871127ClinicalTrials.gov
• Renal Mass Biopsy Prior to Surgical Excision: Practice, Diagnostic Performance, and Impact on Management in the UroCCR Registry (Ancillary Study No. 118)#250227HAL (France)
• A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.#807674ClinicalTrials.gov
• Benmelstobart Plus Anlotinib Is Unlikely to Be Cost-Effective for Advanced Renal Cell Carcinoma: An Integrated Disease Burden and Cost-Effectiveness Analysis.#4442NCBI PubMed Central
• Real-world costs per life-year of targeted therapy, incidence, lifetime health impact, and medical costs of renal cell carcinoma in Taiwan.#146040NCBI PubMed Central
• Sex differences in the association of emotional approach coping with stress and quality of life among patients with renal cell carcinoma.#182218NCBI PubMed Central
• De Novo Serine Synthesis Is a Metabolic Vulnerability That Can Be Exploited to Overcome Sunitinib Resistance in Advanced Renal Cell Carcinoma#257504HAL (France)
• Real-world Clinical Patterns Of Care And Outcomes Among AfME mRCC Patients Receiving Sunitinib as First Line Therapy.#917587ClinicalTrials.gov
• Spanish Retrospective Study to Evaluate the Efficacy and Safety of Targeted Therapies After Pazopanib as First-line Therapy#981129ClinicalTrials.gov
• Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the Urothelium#807537ClinicalTrials.gov
• Perioperative and Mid-Term Oncological and Functional Outcomes After Partial Nephrectomy for Entirely Endophytic Renal Tumors: A Prospective Multicenter Observational Study (The RECORD2 Project)#630578IRIS
• Assessment of Oncological and Functional Outcomes After Robot Assisted Partial Nephrectomy Versus Laparoscopic Partial Nephrectomy#803537ClinicalTrials.gov
• A Phase 2 Study of Durvalumab (MEDI4736) and Oleclumab (MEDI9447) in Multi-Cancer Populations With Correlation to Clinical, Molecular and Immunologic Parameters With DNA MethylaTION#471463ClinicalTrials.gov
• Semantic-Guided Multimodal Preprocessing for Vision Transformer-Based Clear Cell Renal Cell Carcinoma Grading#821360arXiv (All)
• A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies#180380ClinicalTrials.gov
• Study to the Optimal Duration of Therapy With Oral Angiogenesis Inhibitors#828885ClinicalTrials.gov